Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions
Rozalyn L. Rodwin(Yale University), Maryam B. Lustberg(Yale Cancer Center), Namrah Z. Siddiq(Yale University), Barbara E. Ehrlich(Yale University)
Cited by 32
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
|Nature Reviews Clinical Oncology|2023|296
Triple-negative breast cancer: promising prognostic biomarkers currently in development
|Expert Review of Anticancer Therapy|2020|236